- Home
- CMPS vs BARK Comparison
CMPS vs BARK Comparison
Compare CMPS & BARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- BARK
- Stock Information
- Founded
- CMPS 2020
- BARK 2011
- Country
- CMPS United Kingdom
- BARK United States
- Employees
- CMPS N/A
- BARK N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- BARK Department/Specialty Retail Stores
- Sector
- CMPS Health Care
- BARK Consumer Discretionary
- Exchange
- CMPS Nasdaq
- BARK Nasdaq
- Market Cap
- CMPS 280.2M
- BARK 308.9M
- IPO Year
- CMPS 2020
- BARK N/A
- Fundamental
- Price
- CMPS $4.03
- BARK $1.90
- Analyst Decision
- CMPS Strong Buy
- BARK Buy
- Analyst Count
- CMPS 6
- BARK 2
- Target Price
- CMPS $33.60
- BARK $2.20
- AVG Volume (30 Days)
- CMPS 666.3K
- BARK 1.3M
- Earning Date
- CMPS 10-31-2024
- BARK 02-05-2025
- Dividend Yield
- CMPS N/A
- BARK N/A
- EPS Growth
- CMPS N/A
- BARK N/A
- EPS
- CMPS N/A
- BARK N/A
- Revenue
- CMPS N/A
- BARK $488,881,000.00
- Revenue This Year
- CMPS N/A
- BARK $3.23
- Revenue Next Year
- CMPS N/A
- BARK $10.01
- P/E Ratio
- CMPS N/A
- BARK N/A
- Revenue Growth
- CMPS N/A
- BARK N/A
- 52 Week Low
- CMPS $3.86
- BARK $0.74
- 52 Week High
- CMPS $12.75
- BARK $2.56
- Technical
- Relative Strength Index (RSI)
- CMPS 37.75
- BARK 45.11
- Support Level
- CMPS $3.86
- BARK $1.84
- Resistance Level
- CMPS $4.20
- BARK $2.26
- Average True Range (ATR)
- CMPS 0.29
- BARK 0.14
- MACD
- CMPS 0.00
- BARK -0.06
- Stochastic Oscillator
- CMPS 16.59
- BARK 8.39
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.